(0.05%) 5 520.00 points
(0.10%) 39 882 points
(0.16%) 19 783 points
(0.01%) $81.64
(0.46%) $2.82
(-0.32%) $2 337.00
(-0.03%) $29.52
(0.26%) $1 004.40
(0.03%) $0.932
(0.03%) $10.54
(0.01%) $0.788
(-0.57%) $87.50
5.61% $ 2.07
Live Chart Being Loaded With Signals
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers...
Stats | |
---|---|
Dzisiejszy wolumen | 1 206 |
Średni wolumen | 4 622 |
Kapitalizacja rynkowa | 23.89M |
EPS | $-0.130 ( Q4 | 2023-12-31 ) |
Następna data zysków | ( $0 ) 2024-07-22 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-7.14 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
CytoMed Therapeutics Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CytoMed Therapeutics Finanse
Annual | 2023 |
Przychody: | $507 735 |
Zysk brutto: | $504 007 (99.27 %) |
EPS: | $-0.390 |
FY | 2023 |
Przychody: | $507 735 |
Zysk brutto: | $504 007 (99.27 %) |
EPS: | $-0.390 |
FY | 2022 |
Przychody: | $363 912 |
Zysk brutto: | $355 192 (97.60 %) |
EPS: | $-0.410 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
CytoMed Therapeutics
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company\'s lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, which utilizes iPSC as a starting material to generate gdNKT, a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT, a product candidate that consists of expanded gamma delta T cells, and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers. The company was incorporated in 2018 and is headquartered in Singapore.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej